東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back to Search results for [ null ]

Switch To: Labeled | MARC Mode | ISBD

Prevention of infection in femoral i...

Rossi, Shawn L.

Linked to FindBook

Google Book

Amazon

博客來

Prevention of infection in femoral implants: Development and evaluation of antibiotic-loaded biomaterials.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Prevention of infection in femoral implants: Development and evaluation of antibiotic-loaded biomaterials./
Author:	Rossi, Shawn L.
Description:	61 p.
Notes:	Adviser: A. Omri.
Contained By:	Masters Abstracts International43-02.
Subject:	Engineering, Biomedical. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=MQ93576
ISBN:	9780612935761

Prevention of infection in femoral implants: Development and evaluation of antibiotic-loaded biomaterials.
Rossi, Shawn L.

Prevention of infection in femoral implants: Development and evaluation of antibiotic-loaded biomaterials. - 61 p.

Adviser: A. Omri.

Thesis (M.Sc.)--Laurentian University (Canada), 2004.

Polyhydroxyalkanoates (PHA) are natural polymer derived from microbial origin. Poly(3-hydroxybutyrate) (PHB) and its copolymer with hydroxyvalerate (PHBV) with varying hydroxyvalerate (HV) ratios is the most common member of the biopolymer group. These polymers are biodegradable and biocompatible showing excellent potential as orthopaedic devises because of their chemical properties promoting bone growth. The integration of an antibiotic such as gentamicin in the polymer-coated implant would inhibit the growth of bacteria. This research project focused on designing a drug delivery system that could release gentamicin at a constant rate for more then 6 weeks in order to discourage post-surgery bacterial infections. PHBV was chosen as the carrier for gentamicin. We utilized scanning electron microscopy (SEM) and porosity assay to further analyze its physical properties. The antibiotic release rate was calculated and confirmed by microbiological methods to ensure a release rate of above the minimum inhibitory concentration for the organisms. The release system was subjected to a bacterial adherence assay to determine its efficacy. (Abstract shortened by UMI.)

ISBN: 9780612935761Subjects--Topical Terms:

1017684
Engineering, Biomedical.

Prevention of infection in femoral implants: Development and evaluation of antibiotic-loaded biomaterials.
LDR:02054nam 2200277 a 45 001 947112
005 20110523
008 110523s2004 ||||||||||||||||| ||eng d
020 $a 9780612935761
035 $a (UMI)AAIMQ93576
035 $a AAIMQ93576
040 $a UMI $c UMI
100 1 $a Rossi, Shawn L. $3 1270531
245 1 0 $a Prevention of infection in femoral implants: Development and evaluation of antibiotic-loaded biomaterials.
300 $a 61 p.
500 $a Adviser: A. Omri.
500 $a Source: Masters Abstracts International, Volume: 43-02, page: 0571.
502 $a Thesis (M.Sc.)--Laurentian University (Canada), 2004.
520 $a Polyhydroxyalkanoates (PHA) are natural polymer derived from microbial origin. Poly(3-hydroxybutyrate) (PHB) and its copolymer with hydroxyvalerate (PHBV) with varying hydroxyvalerate (HV) ratios is the most common member of the biopolymer group. These polymers are biodegradable and biocompatible showing excellent potential as orthopaedic devises because of their chemical properties promoting bone growth. The integration of an antibiotic such as gentamicin in the polymer-coated implant would inhibit the growth of bacteria. This research project focused on designing a drug delivery system that could release gentamicin at a constant rate for more then 6 weeks in order to discourage post-surgery bacterial infections. PHBV was chosen as the carrier for gentamicin. We utilized scanning electron microscopy (SEM) and porosity assay to further analyze its physical properties. The antibiotic release rate was calculated and confirmed by microbiological methods to ensure a release rate of above the minimum inhibitory concentration for the organisms. The release system was subjected to a bacterial adherence assay to determine its efficacy. (Abstract shortened by UMI.)
590 $a School code: 1100.
650 4 $a Engineering, Biomedical. $3 1017684
650 4 $a Health Sciences, Medicine and Surgery. $3 1017756
690 $a 0541
690 $a 0564
710 2 $a Laurentian University (Canada). $3 1019463
773 0 $t Masters Abstracts International $g 43-02.
790 $a 1100
790 1 0 $a Omri, A., $e advisor
791 $a M.Sc.
792 $a 2004
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=MQ93576